We have long thought that CMS’ hospital readmission penalty program is moronic and unfair and a study carried in Health Affairs give further support to that view. (HA Article) The CMS program is built on a 30-day readmission measure, with the assumption that hospitals are capable of controlling care in the time frame after discharge. As the study points out, there is no empirical evidence supporting this assumption. The researchers examined what proportion of variation in hospital readmission rates appeared to be the responsibility of hospitals and what was due to other factors, such as patient or community demographics. They used all-payer data sets from four large states to conduct the analysis. They tested a variety of post-discharge intervals, from one to 90 days, to ascertain the variation across hospitals in those intervals, looking generally and at readmissions for the specific diagnoses included in the CMS program. The overall 30-day readmission rate was 15.5%, with unplanned readmissions represented 90% of all readmissions. The thirty-day readmission rate was 17.5% for heart attacks, 24% for heart failure, 17.6% for pneumonia. Patients in low-income and rural areas had much higher readmission rates. The variation across hospitals was relatively small at all intervals, but was most significant in the first few days after discharge. By thirty days after discharge, the current CMS time-period, inter-hospital variation had basically become quite low and was much less of a factor than geo-demographic ones. The conclusion of the authors was that if CMS is trying to address readmissions that are within the hospital’s control, it should change the measuring period to 5 to 7 days after discharge. As I have said repeatedly, an even better idea is to look readmission by readmission and determine which ones actually were the avoidable fault of the hospital.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
What do you get when you combine a company with a commodity business model, that out of desperation massively overpays for another company that has a commodity business model? $10...
July 27, 2022
The “stupid” model for health care venture capital investing is alive and well. Everside health, which operates primary care clinics and has grown by acquiring other failing health care businesses,...
July 26, 2022
Apparently not even a cute name can save you if you have a stupid business. I constantly bemoan the mis-application of capital and health care is Exhibit A. Olive, another...
July 26, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace